INNOVACAP

Innova Captab Share Price

₹916.90 +13.25 (1.47%)

21 Apr, 2025 04:39

SIP TrendupStart SIP in INNOVACAP

Start SIP

Performance

  • Low
  • ₹891
  • High
  • ₹924
  • 52 Week Low
  • ₹421
  • 52 Week High
  • ₹1,260
  • Open Price₹895
  • Previous Close₹904
  • Volume59,550

Investment Returns

  • Over 1 Month + 4.43%
  • Over 3 Month -11.36%
  • Over 6 Month + 22.91%
  • Over 1 Year + 95%
SIP Lightning

Smart Investing Starts Here Start SIP with Innova Captab for Steady Growth!

Invest Now

Innova Captab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41.2
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 5,247
  • P/B Ratio
  • 5.9
  • Average True Range
  • 51.9
  • EPS
  • 22.26
  • Dividend Yield
  • 0
  • MACD Signal
  • 10.16
  • RSI
  • 58.91
  • MFI
  • 47.47

Innova Captab Financials

Innova Captab Technicals

EMA & SMA

Current Price
₹916.90
+ 13.25 (1.47%)
pointer
  • stock-down_img
  • Bearish Moving Average 1
  • stock-up_img
  • Bullish Moving Average 15
  • 20 Day
  • ₹871.16
  • 50 Day
  • ₹874.01
  • 100 Day
  • ₹877.78
  • 200 Day
  • ₹811.54

Resistance and Support

909.23 Pivot Speed
  • R3 961.17
  • R2 942.53
  • R1 927.87
  • S1 894.57
  • S2 875.93
  • S3 861.27

What's your outlook on Innova Captab?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Innova Captab Ltd. is a leading pharmaceutical company in India, specializing in the manufacturing of formulations, including tablets, capsules, and syrups. It caters to domestic and international markets with a focus on quality and innovation.

Innova Captab Ltd has an operating revenue of Rs. 1,191.57 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 12% is healthy, ROE of 11% is good. The company has a reasonable debt to equity of 25%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 10% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Innova Captab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-05 Quarterly Results & Others To consider other business matters.
2024-11-07 Quarterly Results
2024-08-09 Quarterly Results
2024-05-29 Audited Results
2024-02-13 Quarterly Results

Innova Captab F&O

Innova Captab Shareholding Pattern

50.9%
10.75%
1.82%
0.35%
27.63%
8.55%

About Innova Captab

  • NSE Symbol
  • INNOVACAP
  • BSE Symbol
  • 544067
  • Managing Director
  • Mr. Vinay Kumar Lohariwala
  • ISIN
  • INE0DUT01020

Similar Stocks to Innova Captab

Innova Captab FAQs

Innova Captab share price is ₹916 As on 21 April, 2025 | 04:25

The Market Cap of Innova Captab is ₹5247 Cr As on 21 April, 2025 | 04:25

The P/E ratio of Innova Captab is 41.2 As on 21 April, 2025 | 04:25

The PB ratio of Innova Captab is 5.9 As on 21 April, 2025 | 04:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23